Johannes Blumenstein1, MD; Suzanne de Waha2,3, MD; Holger Thiele2,3*, MD
1. Department of Cardiology, Heart Centre, Kerckhoff-Klinik, Bad Nauheim, Germany; 2. Medical Clinic II (Cardiology, Angiology and Intensive Care Medicine), University Heart Centre Lübeck, University Hospital Schleswig-Holstein, Lübeck, Germany; 3. German
Percutaneous mechanical circulatory support devices, such as intra-aortic balloon pump (IABP), active left ventricular assist devices (LVAD) or extracorporeal life support (ECLS), are treatment options for selected patients i